A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.
Daily News Roundup
A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.
After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.
A National Institutes of Health working group urges the agency to send most of its chimpanzees to a national sanctuary and halt half of the experiments involving such animals.
A neurodegenerative disease researcher found guilty of fabricating results in funding applications has written an open letter of apology and clarification.
A drug applied to the ears of deaf mice has prompted the regrowth of noise-damaged hair cells and resulted in slight improvements in the animals’ hearing.
Elwood Jensen, whose research inspired new treatments for breast cancer, has passed away at age 92.
Experts in Washington have reached an agreement over how to fund avian influenza research.
After undergoing untested cosmetic surgery that uses stem cells to rejuvenate skin, a woman grew bone fragments in the flesh around one of her eyes.
A researcher tries and fails to garner support for petitions to increase the National Institutes of Health’s budget as sequestration looms.
Biomedical groups propose a simplified system for the disclosure of potential conflicts of interests.